Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients

Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients

Background. Gene polymorphisms affect etanercept’s pharmacokinetics, pharmacodynamics, and side effects. This effect is evidenced by the extensive genetic variation in the drug’s targets. Objectives. This study aims to find the association between different genotypes of the promoter region of the TN...

Full description

Bibliographic Details
Main Authors:	Samer Imad Mohammed, Munaf Hashim Zalzala, Faiq Isho Gorial
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2023-09-01
Series:	Romanian Journal of Rheumatology
Subjects:	adverse effects etanercept rheumatoid arthritis genetic polymorphism tnf-α
Online Access:	https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-03.pdf

Similar Items

Epidemiological and Clinical Factors Affecting the Response to Etanercept Among Patients with Rheumatoid Arthritis
by: Samer Imad Mohammed, et al.
Published: (2022-06-01)

The Effect of TNF-Alpha Gene Polymorphisms At -376 G/A, -806 C/T, and -1031 T/C on The Likelihood of Becoming a Non-Responder to Etanercept in A Sample of Iraqi Rheumatoid Arthritis Patients
by: Samer Imad Mohammed, et al.
Published: (2022-12-01)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
by: Yoshiya Tanaka, et al.
Published: (2019-07-01)

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
by: Nizar A. Jassim
Published: (2015-04-01)

Effectiveness of Combination of Leflunomide and Methotrexate compared to Etanercept in the Treatment of Rheumatoid Arthritis: A systematic review and meta-analysis
by: Rashin Iman, et al.
Published: (2021-07-01)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
by: Jian Cao, et al.
Published: (2019-05-01)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
by: Chen HH, et al.
Published: (2016-02-01)

Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis
by: Xiao-Yu Cai, et al.
Published: (2020-05-01)

The Role of Anti-TNFα Therapy in the Amelioration of Disease Burden in Patients with Refractory Rheumatoid Arthritis
by: Madha Mohammed Sheet, et al.
Published: (2014-06-01)

Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
by: Eugen Feist, et al.
Published: (2022-02-01)

Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
by: Maria N. Chamurlieva, et al.
Published: (2021-10-01)

Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)
by: Siegfried Wassenberg, et al.
Published: (2022-10-01)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
by: Mahmood NMA, et al.
Published: (2018-08-01)

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
by: Areej S. Albahdal, et al.
Published: (2024-02-01)

Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis
by: Rui Hu, et al.
Published: (2023-02-01)

Etanercept
by: Sibel Alper
Published: (2022-04-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01)

Association of TNF-alpha polymorphism (-308 A/G) with high activity of rheumatoid arthritis and therapy response to etanercept
by: Marinković Milena, et al.
Published: (2011-01-01)

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
by: Min-Chan Park, et al.
Published: (2019-05-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Bilateral Panuveitis at Etanercept Initiation for Juvenile Idiopathic Arthritis
by: Kaouther Ben Abdelghani, et al.
Published: (2014-03-01)

Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events: A real‐world finding
by: Zhe Yu, et al.
Published: (2024-02-01)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
by: Al-Ani N, et al.
Published: (2021-04-01)

Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis
by: Anna Szeremeta, et al.
Published: (2023-08-01)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis
by: Audrey Paoletti, et al.
Published: (2022-02-01)

Dermatomyositis–lupuslike syndrome overlap under treatment with etanercept for rheumatoid arthritis
by: Anna Lyakhovitsky, MD, et al.
Published: (2020-08-01)

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
by: Timothy Beukelman, et al.
Published: (2021-08-01)

Terapia com anti-TNF na amiloidose renal em artrite reumatoide refratária: uma nova perspectiva terapêutica Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective
by: Christiane Aguiar Nobre, et al.
Published: (2010-04-01)

The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry
by: Favalli EG, et al.
Published: (2018-05-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
by: Anna Felis-Giemza, et al.
Published: (2019-10-01)

Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial
by: Stanley Cohen, et al.
Published: (2019-03-01)

Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
by: Janusz Jaworski, et al.
Published: (2019-05-01)

Immunologic Parameters for Disease Activity in Rheumatoid Arthritis
by: E Riyadh Mohsen, et al.
Published: (2021-10-01)

Effect of NLRP3 inflammasome genes polymorphism on disease susceptibility and response to TNF-α inhibitors in Iraqi patients with rheumatoid arthritis
by: Abdullah Abbas Awni, et al.
Published: (2023-06-01)

THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01)

Using etanercept to maintain remission of psoriatic arthritis during pregnancy
by: Ibrahim A Al-Homood, et al.
Published: (2014-01-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Influence of promoter polymorphisms of the TNF-α (-308G/A) and IL-6 (-174G/C) genes on therapeutic response to etanercept in rheumatoid arthritis
by: Jančić Ivan, et al.
Published: (2015-01-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

Palisaded neutrophilic and granulomatous dermatitis associated with the initiation of etanercept in rheumatoid arthritis: a case report
by: Chia-Lun Chou, et al.
Published: (2011-12-01)